Cannabis Africa Series Part 1: Giant potential in Africa for residents and companies

Cannabis is well known across the continent of Africa, being both cultivated and consumed widely. In most of the countries though, it is still considered illegal substance. Very few African governments have taken legislative steps towards decriminalization and utilization of the business opportunities the growing global cannabis market has to offer. Estimates show that around

Our Cannabis/-Biotech company gives hope to people suffering from the neuropsychiatric disorder ‘Fragile X Syndrome (FXS)’!

As the second most common chromosomal disorder after Down syndrome, 22q is caused by a small missing piece of the 22nd chromosome. The deletion occurs near the middle of the chromosome at a location designated q11.2. It is considered a mid-line condition, with physical symptoms including characteristic palate abnormalities, heart defects, immune dysfunction, and esophageal

Our Cannabis/-Biotech company gives hope to people suffering from the neuropsychiatric disorder ‚Autism Spectrum Disorder (ASD)’!

The term “autism” comes from the Greek and means “to be very self-reliant”. By Leo Kanner and Hans Asperger the term was first used for children with a profound developmental disorder. Autistic disorders can be very different. Today we speak of autism spectrum disorders (ASD). People with a disorder from the autism spectrum perceive their

Glimmer of Hope for people with ‚Epileptic Encephalopathies (DEE) ‘ from new Biotech-Pearl „GW Pharma 2.0“

Glimmer of Hope for people with ‚Epileptic Encephalopathies (DEE) ‘ from new Biotech-Pearl „GW Pharma 2.0“   Developmental & Epileptic Encephalopathies (DEE) are a heterogeneous group of rare and ultra-rare epilepsy syndromes that manifest with seizures, behavioral disturbances, or EEG abnormalities that can directly worsen cognition and behavior. These disorders are often progressive and are